key: cord-0333652-hxeeh0e6
authors: Hendersonn, J.; Mantso, T.; Ali, S.; Gross, R.; Muller, J. A.; Wilkinson, A.; Shah, K.; Usher, L.; Auld, B.; Nelson, A.; Cheung, W.; Namdeo, A.; Combrinck, M.; Hackney, P.; Turgul, V.; Jajah, E.; Athanasiou, N.; Nikolouzakis, T.; Rokka, C.; Wright, E.; Zafiropoulos, A.; Kale, I.; Smith, D.; Kofteridis, D. P.; Tsatsakis, A.; Munch, J.; Katsaounou, P. A.; Kotanidou, A.; Lagiou, P.; Magiorkinis, G.; Moschos, S. A.
title: Airborne Pathogen Detection in Fine Aerosol Exhaled Oral Breath Condensates
date: 2022-05-27
journal: nan
DOI: 10.1101/2022.05.25.22275435
sha: b23f1254df0fa39ace88b9907276df0b379acf49
doc_id: 333652
cord_uid: hxeeh0e6

Rationale: Exhaled breath condensate (EBC) promises a valuable, non-invasive, and easy to obtain clinical sample. However, it is not currently used diagnostically due to poor reproducibility, sample contamination, and sample loss. Objective: We evaluated whether a new, hand-held EBC collector (PBM-HALETM) that separates inertially impacted large droplets (LD) before condensing the fine aerosol (FA) fraction, in distinct self-sealing containers, overcomes current limitations. Methods: Sampling consistency was determined in healthy volunteers by microbial culture, 16S phylogenetics, spectrophotometry, RT-PCR, and HILIC-MS. Capture of aerosolised polystyrene beads, liposomes, virus-like particles, or reporter pseudotyped virus was analysed by nanoparticle tracking analysis, reporter expression assays, and flow cytometry. Acute symptomatic COVID-19 case tidal FA EBC viral load was quantified by RT-qPCR. Exhaled particles were counted by laser light scattering. Measurements and Main Results: Salivary amylase-free FA EBC capture was linear (R2=0.9992; 0.25-30 min) yielding RNA (6.03 g/mL) containing eukaryotic 18S rRNA (RT-qPCR; p<0.001) but not human GAPDH or beta actin mRNA, and 141 non-volatile metabolites including eukaryotic cell membrane components, and cuscohygrine 3 days after cocaine abuse. Culturable aerobe viability was condensation temperature-dependent. Breath fraction-specific microbiota were stable, identifying Streptococcus enrichment in a mild dry cough case. Nebulized pseudotyped virus infectivity loss <67% depended on condensation temperature, and particle charge-driven aggregation. No SARS-CoV-2 genomes were detected in convalescent or acute COVID-19 patient tidal breath FA EBC.

Introduction compound signatures, have been correlated with pathological states including lung cancer (8, 9) , pulmonary fibrosis (10), bronchoconstriction (11), physiological shock (12) and even neurological disorders (12).

Despite the apparent diagnostic potential of EBC, clinical adoption has been restricted to volatile compound mass spectrometry for the detection of Helicobacter pylori gastric infection (13) . Challenges beyond this indication centre on the poor reliability of EBC collectors (3, 14) ; thus, in 2005 (14) and again in 2017 (3) To specifically address the key technical challenges of EBC sampling reproducibility, salivary and ambient matter contamination, sample loss, and healthcare professional safety (3, 14) , we have developed a new, hand-held exhaled breath condensate collector (PBM-HALE TM ). This device inertially impacts and collects the LD fraction of exhaled breath, before condensing FA with enhanced efficiency in a separate specimen container. The aims of this study were to evaluate the capacity of this device to isolate distal lung FA EBC free of oral and upper airway contaminants, the classes of biomarkers identifiable in the resulting FA EBC samples, and whether putative causal agents of symptomatic respiratory infections can be safely collected and detected in orally exhaled tidal breath. the closed position isolating the FA EBC. Samples were placed on wet ice before centrifuging at 4,000xg for 1 minute to pool the EBC at the bottom of the tube. The sample was then either immediately processed or stored at -80°C. The LD fraction was removed from PBM-HALE TM by syringe and needle puncture of the saliva trapcontaining mouthpiece. Fresh saliva samples were collected by drooling for 2 minutes into a microcentrifuge tube, spun at 4,000xg for 1 minute, after which the supernatant was added to a clean tube to separate it from any oral debris.

Sample volumes of 0.18mL were added to 0.02mL of 10x RIPA buffer (100mM Tris-Cl pH 8.0, 0.5% sodium deoxycholate, 0.5% SDS, 10% Triton X-100, 1.4M NaCl; Thermo Fisher Scientific), chilled on ice for 25min and vortexed at maximum speed intermittently. Lysate volumes of 0.15mL and bovine serum albumin protein standards (2 -20ng ; Thermo Fisher Scientific) were then mixed with 0.15mL of the micro BCA kit working reagent (Thermo Fisher Scientific) and absorbance was measured at 562nm after incubating at 37°C for 4-6 hours using a Spark® Cyto 96 well plate reader (Tecan, Männedorf, Switzerland). Sample protein concentrations were then calculated using the equation of the line of best fit for the standard curve. Undiluted tidal breath LD samples, or fresh saliva samples subjected to a freeze-thaw cycle on dry ice and diluted 1:200 with physiological saline were analysed using an α-amylase kinetic assay (Salimetrics LLC, Carlsbad, CA) following the manufacturer's protocol.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint For laboratory samples, RNA was extracted by adding 0.2mL of each sample to 0.8mL of TRIzol (Thermo Fisher Scientific) and virgorously vortexing for 1min. An 80% fraction of the upper aqueous phase was removed to prevent interphase DNA contamination. After precipitating in 100% isopropanol and washing with 75% ethanol (Thermo Fisher Scientific), RNA was eluted in 0.02mL nuclease-free water. RNA concentrations were then quantified using an ND-1000 Nanodrop spectrophotometer (Thermo Fisher Scientific) at an absorbance of 260nm. RNA samples were converted to cDNA using a maxima first strand cDNA synthesis kit (Thermo Fisher Scientific).

qPCR was performed using a PrecisionPLUS qPCR mastermix with SYBR Green (PrimerDesign Ltd., Chandler's Ford, UK) using either pan-eukaryotic 18S rRNA, human GAPDH, or human β-actin primers (Eurofins Scientific, Luxembourg). Thermal cycling was performed on a BioRad CFX96 (BioRad, Watford, UK) as follows: 2min at 95°C, then 40 cycles of 10sec at 95°C and 60sec at 60°C, with fluorescence measured via the SYBR channel after each cycle. Melt curves were assessed post-PCR to ensure no non-specific amplification occurred.

Volumes of 0.2mL (nasopharyngeal swabs) or up to 1mL (FA EBC) of clinical samples were RNA extracted using the Complex800_V6_DSP protocol with the QIAsymphony DSP/Pathogen Midi kit (SafeBlood BioAnalytica SA, Athens, Greece); final elution volumes were 0.06mL. SARS-CoV-2 RNA load was quantified using the VIASURE SARS-CoV-2 (ORF1ab and N genes) Real Time PCR Detection kit for the specific identification and differentiation of SARS-CoV-2 with a manufacturer's stated analytical limit of detection of 10 target copies per reaction (5μl RNA extract in a 20μl reaction; CerTest Biotec, Zaragoza, Spain), using the internal control at a ratio of 0.1μl internal control/μl eluate. Viral load was expressed as the average Ct of the positive targets per sample.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint

Blood agar (0.5% peptone, 0.3% yeast extract, 1.5% agar, 0.5% NaCl (Formedium Ltd., Norfolk, UK), 5% defibrillated horse blood (Scientific Laboratory Supplies, Nottingham, UK), pH 7.4) and nutrient agar (0.5% peptone, 0.3% yeast extract, 1.5% agar, 0.5% NaCl, pH 7.4; Formedium Ltd.) plates were poured aseptically and stored at 4°C <1 week. Frozen samples were thawed at room temperature and 0.5mL of sample was pipetted onto the agar plates aseptically and spread using a sterile loop.

Plates were incubated at 37°C for 48 hours, after which colonies grown on the plates were photographically documented.

16S rRNA microbiota analysis DNA extraction was undertaken using a modified protocol the Purelink genomic DNA kit (Thermo Fisher Scientific) as previously described (27 were used to bring mastermix concentration to 1x in 0.05mL reactions, and samples were barcoded prior library construction and sequencing. Data analysis was . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint performed with QIIME using RDP v11.2 as a reference database; principal coordinate analysis was undertaken using Bray Curtis distances on normalized datasets.

For kitome-corrected microbiomics in PBM-HALE TM -collected samples vs RNAse-free water, the same library preparation procedure was adopted, but V4 16S rRNA primers and an Illumina MiSeq (Illumina UK Ltd., Cambridge, UK) platform was used as previously described with post-library construction barcoding (28) at the NU-OMICS DNA sequencing research facility (Northumbria University). Data analysis was performed with Mothur (v1.44.1) using RDP v11.5 and contaminating OTUs were removed using the frequency model in decontam (29). Statistical analysis was performed in R using the phyloseq package to perform alpha and beta diversity measures.

All chemicals used in the EBC process and liquid chromatography/mass spectrometry (LC/MS) profiling were Optima grade or equivalent (Thermo Fisher Scientific). The lyophilised EBC samples were reconstituted in 0.05mL of 95/5 v/v acetonitrile and LC/MS water, sonicated for 15min on ice/water bath and centrifuged at 16,580 x g, 4 o C for 15min. Supernatants were filtered via 0.22µm Corning Costar Spin-X cellulose acetate spin filters (Thermo Fisher Scientific) and transferred to 1.5 autosampler vials with 0.2mL microinsert. 0.01mL of each sample were pooled together to create a master pool for AcquireX template data-dependent analysis. Extraction blanks were also included to generate the ion excursion list as part of the AqurieX workflow. MS signals associated to the processing workflow were identified using the extraction blanks and an ion exclusion list were generated as part of the data acquisition . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint workflow. Metabolite profiling was performed on a Thermo Fisher Scientific Vanquish Liquid chromatography chromatographic separation system connected to an IDX High Resolution Mass Spectrometer. The Hydrophilic Liquid Interaction Chromatography (HILIC) mode was applied and chromatographic separation was archived using a Waters Acquity UPLC BEH amide column (2.1 x 150mm with particle size of 1.7μm) operating at 45 o C with a flow rate of 0.2mL/min. The LC gradient consisted of a binary buffer system, buffer A (95% Water/5% acetonitrile) and Buffer B (95% acetonitrile/5% water), both buffers containing 10mM ammonium formate. Independent buffers systems were used for positive and negative mode acquisition respectively; for positive mode the pH of buffers were adjusted using 0.1% formic acid and for negative 0.1% ammonia solution. The LC gradients were the same for both polarities, T0 95% B at T0 hold for 1.5min and linearly decreased to 50% B, at 12min held for 4.5mins, and returned to starting conditions and held for further 4.5min (column stabilization).

The voltage applied for positive mode and negative mode was 3.5kV and 2.5kV respectively. The injection volume used for positive mode was 8μL and negative mode 12μL. The MS data were acquired using the AcquieX acquisition workflow (data dependent analysis using the following operating parameters: MS1 mass resolution 60K, for MS2 30K. Stepped energy (HCD) 20, 25, 50 was applied with a scan range 100-1000, RF len (%) 35, AGC gain intensity threshold was set to 2e 4 25%, and custom injection mode was used with an injection time of 54ms. An extraction blank was used to create a background exclusion list and a pooled QC were used to create the inclusion list. The voltage applied for positive mode and negative mode was 3.5kV and 2.5kV respectively. The HESI condition for 0.2mL were as follows: Sheath Gas: 35; Aux Gas 7 and Sweep Gas of 0; Ion Transfer tube Temp: 300 o C and Vaporizer

Temp 275 o C. Post data processing: The HILIC Positive and Negative data sets were . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint vs SSC-A histogram, whereby <0.1% of negative control cells were included and thus denoted as GFP-positive.

Nanoparticle suspensions diluted in cell culture media, physiological saline, or deionized water were nebulized for 5-15 min using a PARI Turboboy SX or PARI Boy Classic (PARI Medical Ltd., Byfleet, UK) devices that generate aerosols with a mass median diameter of 3.5µm wherein 67% of the mass is in particles <5µm. Aerosols were routed directly into PBM-HALE TM using a custom 3D printed polylactic acid adapter.

The VSV-GFP stock (8.26x10 5 IFU/mL) was diluted to 5. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint nanoparticle tracking analysis. Lentiviral VLPs (MLVgagYFP-VLPs) and SARS-CoV-2-VLPs were prepared as previously described (33, 34). Nanoparticle size, zeta potential, and concentration were determined using a ZetaView TWIN (ParticleMetrix GmbH, Inning am Ammersee, Germany), at 480nm with the exception of SARS-CoV-2-VLPs, which are not tagged and were analyzed in scatter mode.

The aerosolized VSV-GFP suspensions collected by PBM-Hale TM were allowed to thaw on ice and centrifuged at 1,000xg for 1min at 

Statistical analyses were carried out in GraphPad Prism v9.3.1 (GraphPad Software, San Diego, CA). Sampling consistency was determined by plotting sample volumes . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint over time or number of breaths sampled, and performing regression analyses after anchoring Y axis intercepts to zero and computing the probability of regression slope difference. Differences in culturable microbe load, particle counts/concentrations, and analyte levels were compared by ANOVA followed by post hoc tests for pairwise comparisons (Tukey multiple comparison tests for low replicate virological and qPCR experiments (n=3-5) with limited variable analysis, Benjamini and Yekutieli false discovery rate correction for limited sample (n=3-8) 2-way ANOVA comparisons of operational taxonomic unit (OTU) relative abundance, and Holm-Šídák multiple comparisons for large replicate (aerosolized particle count and NTA) experiments).

Early experiments were conducted with an EBC collector assembled using laboratory consumables ( Figure 1A ). Healthy volunteer sampling indicated linear FA EBC volume capture vs the number of tidal oral exhalations (R 2 0.8872-0.9960), consistent between consecutive days (slope difference: p=0.8112, n=3; Figure 1B ), with highest yields at -100 o C condensation ( Figure 1C ). By contrast, no condensation was observable nor aqueous matter retrievable from devices left open to the environment by removing the tube clamps for up to 30min. Under aerobic conditions nutrient agar plating of the FA fraction demonstrated low biomass but culturable bacteria, whose viability was condensation temperature-dependent ( Figure 1D ). Subjecting LD and FA samples to endpoint PCR for the 16S rRNA gene consistently demonstrated microbial DNA detection, which was free of background contamination (no kitome) only when . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint amplification was performed without nucleic acid extraction or purification ( Figure 1E ). This finding reflected parallel experiments indicating that freeze/thawing rendered viral nucleic acids directly accessible to PCR (30).

To better understand the microbial diversity of these two sample types, 16S rRNA amplicons generated directly from samples donated by a healthy volunteer over 4 consecutive days, were subjected to Ion Torrent PGM sequencing. The resulting microbiota indicated a stable proteobacteria-dominated (59.1% (±6.75)) signature in FA EBC that was consistently different to the paired, firmicutes-dominated (48.5% (±8.69)) LD samples ( Figure 1F ). Genus level analysis further indicated that none of the OTUs with a >1% relative abundance in one sample set was present in the other, with Prevotella, Streptococcus, and Veillonella spp. accounting for the LD dominating genera, whilst Enterococcus and Pseudomonas dominated the FA fraction ( Figure   1G ). These results suggested that this EBC collector design may favour the isolation of oral LD contaminants from respiratory FA.

Key principles behind the laboratory prototype ( Figure 1A ) were implemented in PBM-HALE TM (WO2017153755 (A1)) whilst introducing changes for improved safety and ease of use ( Figure 2A ; video 1 online). These included enlargement of the conducting tubes to 1cm diameter to eliminate tidal airflow resistance, a tamper-resistant coolant chamber, and a one-way valve preventing cooled air inhalation through the device.

However, early attempts failed to reproduce FA sampling linearity ( Figure S1A ) or yield FA samples free of salivary alpha amylase, indicating substantial sample loss or even condensate-driven blockage of the FA platform ( Figure S1B ), due to component . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint dimensions, material-and device architecture-dependent heat gradients between components, and thermophoretic condensate formation occluding airflow. These were resolved by parametric architecture optimization to achieve high FA sampling linearity across 2-30min tidal breathing sampling periods (R 2 =0.9987-0.9995, n=5 volunteers; Figure 2B ).

To better understand how exhaled breath is condensed in PBM-HALE TM we first measured device surface temperature during tidal breathing to note no quantifiable change in condensing surface temperature when sampling at either at 0 o C or -100 o C.

Gas phase water nucleates upon surfaces, dry, and aqueous particles at low temperatures (35). We therefore reasoned that swelling fine aerosols in the PBM-HALE TM condenser would experience more gravitational sedimentation and inertial impaction. Computation flow modelling of a typical 500mL tidal oral exhalation through PBM-HALE TM supported this tenet since the FA sample tube rapidly cooled during the inhalation phase, when flow through the device was paused ( Figure 2C ), down to -80 o C when condensing with dry ice (video 2 online). To test this hypothesis, we measured tidal exhaled particle counts per second at the PBM-HALE TM exhaust over 3min, as a function of condensation temperature. These experiments showed a reduction in ultrafine particle counts (<0.3 µm; p<0.01) on account of 0 o C or -100 o C condensation, matched by simultaneous increases in 0.5-10 µm particle sizes (p<0.05 to 0.0001), with a consistent trend supporting a condensation temperature-dependent effect on particle size ( Figure 2D -I). Taken together these results indicated that the FA mass was most effectively cooled, allowing FA to swell in size and condense onto PBM-HALE TM during the inspiration phase of the breath cycle.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

As with early experiments, FA EBC aerobic microbe viability was condensation temperature-dependent (n=3; Figure 3A) ; however, continuous sampling could not extend beyond 40 min due to loss of coolant contact with the condensation surface (n=5; Figure S1C ). Furthermore, LD microbial load was lower than that of drooled saliva, indicating that exhaled LD may consist of salivary and respiratory droplets.

Accordingly, salivary alpha amylase activity was lower in the LD fraction vs drooled saliva (n=5; Figure 3B ); yet neither 5 exhalations ( Figure S1D ) nor 30 mins of continuous sampling yielded any assayable salivary alpha amylase activity in the FA fraction (<0.4units/mL; n=5), even after 10x sample concentration by lyophilisation.

Taken together, these data reinforced the premise that PBM-HALE TM inertially separates orally contaminated LD for effective lower respiratory tract FA EBC condensate collection.

Focusing therefore analyses on the tidal FA fraction, healthy volunteer samples featured DNA quantities at, or below the limit of detection, and low cell-free protein content, both quantifiable only after 5x lyophilization concentration (~0.833 (±0.117)µg/mL; n=5). In contrast, there were appreciable RNA quantities (6.03 (±1.61)µg/mL; n=5), at concentrations stable irrespective of sampling duration ( Figure   3C ,D). RT-qPCR analysis indicated 5.21x (±0.88) above-background enrichment (p<0.001; n=5; Figure S1E ) for eukaryotic 18S rRNA in 20 tidal breath samples, rising to 9,432x (±923) for a 30 min sample, with total yield correlating to sampling period length (R 2 =0.9677; Figure 3E ). In contrast, human GAPDH or beta actin mRNA were below assay detection limits. Interestingly, 260/280nm RNA absorbance ratios (1.52 (±0.09); n=5) indicated the presence of substantial volatile contaminants co-extracted . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Given the established volatile compound content in exhaled breath, we next examined organic analyte content by HILIC-MS. Unlike PCR, direct injection of a 10min, 0.5mL sample resulted in no appreciable peaks; however, injection of extracted samples (n=5) yielded 141 non-volatile compounds <837.5g/mol (phosphatidylethanolamine), of which 20 resulted in multiple hits in the human metabolome database, and 104 were novel compounds ( Figure 3F ; Table 1 ). The most prevalent unique hits included ndecanoylglycine and n-nonanoylglycine among several other eukaryotic cell membrane lipids whose lysis-dependent detection alluded to the presence of intact cells or extracellular vesicles. Other interesting compounds included Nacetylputrescine, a urea cycle byproduct commonly causal of halitosis whose serum elevation is implicated in lung cancer (36) and the pyrrolidine derivative cuscohygrine. This is a coca leaf alkaloid previously presumed to be lost during cocaine fabrication (37) and detected in oral fluids of coca leaf chewers and coca tea drinkers but not cocaine users (38). In this instance cuscohygrine provenance was on account of cocaine nasal consumption ~72hrs ahead of EBC sample collection with PBM-HALE TM indicating that cocaine abuse might be detectable in FA EBC (37).

With the emergence of SARS-CoV-2 we promptly sought to determine if PBM-HALE TM could capture aerosolized viruses in the FA EBC fraction. We first established a BSL2 model of aerosolized virus capture based on GFP-expressing, VSV glycoporteinpseudotyped lentivirus, a similarly sized (~150nm), enveloped RNA virus ( Figure   . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint S2AB). Exposing HEK-293T cells to nebulized VSV-GFP passively routed via PBM-HALE TM indicated virus infectivity was reduced as a function of condensation temperature ( Figure 4AB ). Thus, in line with previous reports with MS2 coliphage and Ebola virus (30) and unlike exhaled aerobic bacteria ( Figures 1A, 3A) , exhaled viruses may not be effectively disrupted by a single freezing/thawing cycle to support direct detection by RT-PCR, or the handling of FA EBC samples as non-infectious.

To better understand how nebulization, condensation, and particle charge interact in affecting nanoparticle structural integrity, we repeated these experiments using synthetic polystyrene beads (PS; -71mV, 118nm), negatively charged liposomes (-72 mV, 188nm), neutral liposomes (-20 mV, 168nm), lentiviral virus like particles (VLP; -31 mV, 193nm) and SARS-CoV-2 VLPs (-17mV, 155nm), measuring the resulting changes in particle size and concentration ( Figure 4CD , Figure S2C ). In line with the VSV-GFP infectivity assay, lentivirus VLP concentration was reduced by 43.7% with a corresponding reduction in particle diameter of 29.4% on account of nebulization (p<0.0001), but not by freezing of the suspension (2.8% reduced concentration, 1.3% reduction in mean size, n=3). Interestingly, no appreciable change in SARS-CoV-2 VLP particle concentration (p>0.999) was observed indicating that PBM-HALE TM capture of SARS-CoV-2 would have minimal impact on virion integrity. It must be noted that SARS-CoV-2-VLPs, unlike lentiviral VLPs, were not fluorescently tagged and tracked by scatter-NTA instead of F-NTA and non-VLP particles may thus be included in this analysis. By stark contrast, negatively charged nanoparticle concentration in PBM-HALE-captured condensates was reduced by 72.6x-98.0x compared to source fluids (p<0.0001), likely on account of freezing-driven aggregation, in a nanoparticle type-dependent manner (PS beads (p<0.0001) > liposomes (p=0.0031)). Taken . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 6E ), suggesting an enhancement of FA EBC capture by more than 6x on account of particle swelling, rather than simply sample dilution or microbial cell, viral particle, or vesicle lysis. Taken together our in vitro, healthy volunteer, and clinical observations indicate that absence of detectable SARS-CoV-2 in tidal FA EBC of acutely symptomatic patients is not an artefact of the sampling or analytical process but a function of viral load, if any, being <120 genome copies per mL of FA condensate (4.72 genomes/min).

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint

The key problems of sampling inconsistency, salivary contamination, and sample loss among EBC collectors (3, 14) gave rise to castigating criticisms (41) over EBC biomarker associations with disease; these persist, restricting clinical translation of this methodology (42, 43). Many of these problems relate to the architecture of EBC collectors. For example, unprotected sampling surfaces such as petri dishes, filter modules, or indeed open-ended condensing tubes risk ambient aerosol condensation and manual handling contamination. Some instruments additionally fail to capture any EBC from some subjects: as in critical care ventilation systems, elephant trunk connectors result in aerosol 'rain out' before substantial aerosol quantities reach the EBC sampling vessel. Nevertheless, reports of high natural variability in exhaled aerosol particle load (44) and relative humidity (45) could also explain such observations. Conversely, some solutions rarely integrate any physical means of salivary droplet separation, resulting in substantial salivary contamination (46, 47) .

Importantly, this risk can be missed if poorly sensitive analytical methods are used (48) . Yet other devices, such as the BioScreen I (49) and II (50), can easily suffer saliva droplet contamination in conducting tubing. 'Fluid film burst' (1) disruption of these droplets may generate contaminating salivary FA, and in some cases the large droplets can be even propelled into the condenser, especially if tubing is angled downwards (51, 52).

We sought to address EBC sampling inconsistency, salivary contamination, and sample loss by a) preventing sample loss in non-condensing instrument parts; b) physically isolating the condensing surface to prevent environmental contamination or . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint evaporative sample loss; and c) implementing basic principles from inhaled therapeutics design (53) to separate saliva-laden LD from the FA. This approach demonstrated good FA EBC volume linearity vs. duration of use, further improved by eliminating flow resistance. It is noteworthy that small changes in device architecture proved critical, underscoring how EBC collector design impacts sample integrity.

Similar observations have been reported by others who have successfully reduced salivary contamination by diverting exhaled breath flow (47) . In the case of PBM-HALE TM however, any contaminating saliva in the FA fraction was below salivary alpha amylase assay detection limits, or > 1,750x diluted by FA.

Dilution is a feature of condensation due to the nucleation of exhaled water vapour on condensers, leading to recommendations of 500x sample concentration to detect analytes reliably (46) . However, in PBM-HALE TM the resulting dilution is only ~14x since it drives exhaled particle enlargement and capture increase by ~6x. This phenomenon is likely universal among EBC condensers where breath remains static in the condenser during the inhalation phase, however condensation temperature decay in some systems will reduce exhaled particle swelling and thermophoresis as condenser temperature rises. Whilst dry ice cooling can sustain condensation temperatures at -100 o C unperturbed for 30 min of continuous use, the optimal condensation temperature in active cooling solutions remains to be determined and should factor energy requirements vs fine aerosol capture efficiency.

Exhaled breath and invasive lung sample microbiomics remains a technically challenging, non-standardized field. The only comprehensive study on EBC . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint microbiomes to date did not find stable communities among technical replicates of EBC collected with R-Tube devices that were subjected to DNA extraction (54). In that study, community diversity 'noise' and inconsistency was common to negative control DNA extractions, unless >2000 16S rRNA gene copies were present per sample-a near-universal background (kitome) bacterial DNA contamination level (54). Past experience with oral microbiome contamination in very low biomass-containing liquid animal samples with viable aerobes (27) indicated that salivary OTUs would be readily detectable in a contaminated FA fraction. We had also found that at least 8-10 freezethaw cycles were necessary for direct amplification of viral RNA in reactions templated with fresh blood (30), yet aerobic bacterial viability in FA EBC was lost in a single freeze-thaw cycle. This motivated us to explore direct 16S rRNA amplicon sequencing library preparation to avoid extraction kit contamination observed by us ( Figure 1E) and others (55). Prevotella, Veillonella, and Streptococcus spp. in LDs with this reduced kitome contamination method were consistent with firmicutes and bacteroides (56) results from invasively obtained lung samples, which are subject to the persistent risk of oropharyngeal contamination even in protected brush specimens (57). A ~60% proteobacteria-dominated FA EBC signature, by contrast, has only been reported in surgically obtained lung resections (58). By taking an extraction-free approach, therefore, kitome contamination is restricted to the sequencing library polymerase, water source, and operator technique. However, in line with the recommendation of Erb-Downward et al., we find technical replicates facilitated above-background respiratory bacterial pathogen detection reliability. Further work is necessary, including an assessment of how exhalation maneuvers affect breath aerosol production and consistency, the impact of infection location, mucous production, mucosal surface hydration, and dyspnoea (59-63).

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint Unlike reports with devices prone to salivary contamination employing comparable analytical methodologies, metabolite and protein content in FA EBC was restricted to at least vesicular material. Whether the membrane compounds detected are of human or microbial origin is still unclear, but past reports of exosomes in EBC (64, 65) and our observation of lung surfactant components point towards the host as their source.

Indeed, exosomes often lack housekeeping gene-coding RNA but are rich in rRNA (66) in line with our observations; future metatranscriptomic studies will establish the diversity and origin of FA EBC RNA and whether this includes miRNAs which are established biomarkers for cancer (67) (68) (69) (70) , lung inflammation (71) (72) (73) , and a number of autoimmune disorders (74-76).

The debate on SARS-CoV-2 airborne transmission (4, 77, 78) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint tube with a cut off tip conducting to a 50 mL tube placed below the 15mL tube, and immersed in coolant, lacking any environmental or salivary contamination prevention, was positive in 25% of cases. In the second study, negative breath samples were also matched by salivary negative samples in patients that were positive by nasopharyngeal swab pointing to saliva as the source of 'breath' SARS-CoV-2.

Elsewhere, electret filter-based testing did return high concordance in exhaled breath viral load vs nasopharyngeal swabs (88) . Yet this technology does not prevent large droplet contamination of the breath specimen filter, and has only been explicitly tested for methadone capture efficiency alone, as opposed to particle size filtering directly (88, 89) . This reduced the likelihood of ambient contamination, but not necessarily fomite contamination from the subject's hair or skin. Moreover, the device did not dynamically adjust sampling rates in response to patient exhalation rates e.g. during singing vs tidal breathing. This could result in higher inflow from the cone perimeter, potentially increasing fomite and ambient contamination risk. Perhaps more importantly the cone path length allows for aerosol particle size distribution to evolve in response to the sharp temperature and humidity gradients from the respiratory tract to atmosphere.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint Ambient air influx and mixing within the cone would exacerbate this effect (93). In their seminal paper on this sampling method, McDevitt et al (92) reported no ambient air FA particle size changes on account of the device cone and pump operation, but <50% capture efficiency for mechanical aerosol particles <30µm; no particle data was reported for human breath aerosols which differ in humidity and temperature to environmental aerosols. Therefore, although our study is limited by not examining viral load in the salivary amylase-containing LD fraction, our results add weight to an emerging model wherein SARS-CoV-2 emission, at least during tidal breathing, does not implicate FA produced by either acutely symptomatic or hospitalized individuals, but the change in size of LD emissions. Yet, since both particle emission rates rise and particle size distribution changes with increased volume of speech and coughing (59-62), more research is needed to understand if SARS-CoV-2 airborne transmission is a consequence of exhaled FAs or LDs per se, and under which exhalation conditions.

In this study we have evaluated the performance of a new EBC collector design that sought to overcome the key challenges of salivary/ambient contamination, sampling inconsistency and sample loss, and healthcare professional safety (3, 14) . This was achieved in a hand-held format by implementing LD impaction ahead of FA condensation in a high thermal capacity condenser, which yields linear sampling of tidal breath through vapour nucleation during the inspiration phase of the breath cycle.

This physical process promotes highly charged particle aggregation and enlarges FAs to increase capture efficiency by 6x. Resulting FA EBCs have less than 1:1,750 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint contamination of saliva, are enriched in RNA, contain host metabolites of vesicular nature, and micro-organisms whose viability is a function of condensation temperature. Microbiomic analysis of these low biomass samples is achievable, with direct deep sequencing library preparation offering a means of improving upon sample-to-kitome signal problems. However, viral particle disruption cannot be ensured simply through the thermal shock of breath condensation indicating viruses in FA EBCs remain infectious. Use of this device in poorly ventilated clinical wards has confirmed the absence of FA sample contamination from environmental aerosols during device use, and demonstrated that SARS-CoV-2 is not emitted in the tidal breath FA fraction of symptomatic COVID-19 patients at a rate above 4.72 genome copies per min.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. replicates). The net zeta potential (charge) of each particle type is shown. *: p<0.05; **: p<0.01; ***: p<0.001; ****: p<0.0001.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; spike-pseudotyped lentivirus was incubated at room temperature for 24hrs and impact on HEK293T cell infectivity was compared to 4 o C storage. Virus titres were calculated as the mean relative light units/min (n=3, average ± standard deviation; data . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. replicates is depicted in the green-shaded area). The charge (zeta potential) of each particle type is shown.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 27, 2022. ; https://doi.org/10.1101/2022.05.25.22275435 doi: medRxiv preprint

The mechanism of breath aerosol formation

The size and the duration of air-carriage of respiratory droplets and droplet-nuclei

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Modelling the transmission of airborne infections in enclosed spaces

Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers

Exhaled leukotrienes and prostaglandins in asthma

Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection

Respiratory viral infections in the elderly

Approaches to Asthma Diagnosis in Children and Adults

Bioterrorism: From Threat to Reality

Medical devices in allergy practice

Exhaled aerosol increases with COVID-19 infection, age, and obesity

Measurement of temperature and relative humidity in exhaled breath

Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate

Human breath metabolomics using an optimized non-invasive exhaled breath condensate sampler

Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations

Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour

Exhaled respiratory particles during singing and talking

Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing

Aerosol emission and superemission during human speech increase with voice loudness

Modality of human expired aerosol size distributions

COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea

Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients

Extracellular vesicle-derived microbiome obtained from exhaled breath condensate in patients with asthma

Transcriptome of Extracellular Vesicles: State-of-the-Art

Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis

Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients

Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

A potential role of microvesiclecontaining miR-223/142 in lung inflammation

Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells

Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids

Diagnostic significance of circulating miRNAs in systemic lupus erythematosus

Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy

It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19)

SARS-CoV-2 (COVID-19) superspreader events

Phylogenetic analysis of SARS-CoV-2

Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR

Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)

Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province

SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19

Characterization of exhaled breath particles collected by an electret filter technique

Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing